← All news
Markets
AstraZeneca (LSE:AZN) Wins EU Asthma Nod For Trixeo This Week: How Big Is Respiratory Opportunity?
Highlights The European Commission approved Trixeo Aerosphere for maintenance treatment of asthma. Approval followed positive late-stage KALOS and LOGOS trials and a favourable CHMP opinion. AstraZeneca calls it the first single-inhaler tri…
Covered by 1 outlet
All coverage · 1 article